Lily D'Avila Jing Yang Tee https://orcid.org/0009-0009-1085-6316 Aryan Sharma Edward Alabraba Abed ZaItoun https://orcid.org/0000-0003-3351-6460

Abstract

Synchronous primary malignancies involving the pancreas and duodenum are rare and distinguishing them from direct extension or metastatic spread may be difficult in the periampullary region. We report a 73-year-old man who initially presented with upper gastrointestinal bleeding and was later investigated for weight loss, abdominal pain, dyspepsia, and abnormal liver biochemistry. Preoperative imaging and biopsy identified poorly differentiated adenocarcinoma involving the pancreatic and duodenal region, but the relationship between the lesions remained uncertain. Following pancreaticoduodenectomy, two macroscopically separate tumor sites were identified. Histological examination showed that the pancreatic tumor had features of medullary carcinoma, including syncytial growth, pushing borders, marked lymphocytic infiltration, and mismatch repair deficiency. In contrast, the duodenal tumor showed glandular differentiation, infiltrative invasion, and desmoplastic stroma, but also deficient mismatch repair. Lymph node involvement was seen with the pancreatic tumor but not the duodenal lesion.  This case suggested that synchronous primary tumors should remain in the differential diagnosis when adjacent periampullary lesions show discordant pathological features, and that definitive classification may require integration of gross examination, morphology, selected immunohistochemistry, mismatch repair status, and nodal disease pattern on the resection specimen. The underlying diagnosis of Lynch syndrome provides a novel pathogenesis for these genetically related yet distinct tumors. This diagnosis was important not only for understanding tumor pathogenesis but also for ongoing surveillance and family counselling.

##plugins.themes.bootstrap3.article.details##

Keywords

Synchronous carcinoma, Medullary carcinoma of the pancreas, Duodenal carcinoma, immunohistochemistry, molecular testing, periampullary tumor, mismatch repair deficiency, synchronous primary malignancy

References
1. Schawkat K, Manning MA, Glickman JN, Mortele KJ. Pancreatic Ductal Adenocarcinoma and Its Variants: Pearls and Perils. Radiographics. 2020 Sep-Oct;40(5):1219-1239. doi: 10.1148/rg.2020190184. Epub 2020 Jul 17. PMID: 32678699.
2. Yago A, Furuya M, Mori R, et al. Medullary carcinoma of the pancreas radiologically followed up as a cystic lesion for 9 years: a case report and review of the literature. Surg Case Rep. 2018 Jul 24;4(1):80. doi: 10.1186/s40792-018-0487-3. PMID: 30043132; PMCID: PMC6057860.
3. Verocq C, Racu ML, Bafort D, et al. Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report. Diagn Pathol. 2021 Dec 13;16(1):117. doi: 10.1186/s13000-021-01178-0. PMID: 34895278; PMCID: PMC8667442.
4. Wilentz RE, Goggins M, Redston M, et al. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol. 2000 May;156(5):1641-51. doi: 10.1016/S0002-9440(10)65035-3. PMID: 10793075; PMCID: PMC1876921.
5. Cloyd JM, George E, Visser BC. Duodenal adenocarcinoma: Advances in diagnosis and surgical management. World J Gastrointest Surg. 2016 Mar 27;8(3):212-21. doi: 10.4240/wjgs.v8.i3.212. PMID: 27022448; PMCID: PMC4807322.
6. Meijer LL, Alberga AJ, de Bakker JK, et al. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2018 Sep;25(9):2681-2692. doi: 10.1245/s10434-018-6567-6. Epub 2018 Jun 26. PMID: 29946997; PMCID: PMC6097725.
7. Eriguchi N, Aoyagi S, Hara M, et al. Synchronous or metachronous double cancers of the pancreas and other organs: report on 12 cases. Surg Today. 2000;30(8):718-21. doi: 10.1007/s005950070083. PMID: 10955735.
8. Kim SH. Metachronous pancreatic cancer 18 years after resection of common bile duct cancer: A case report. Front Surg. 2022;9:851524. doi:10.3389/fsurg.2022.851524 PubMed PMID: 36090324; PubMed Central PMCID: PMC9448957.
9. Du Y, Duan Y, Zhang L, et al. A Female With Synchronous Multiple Primary Malignant Tumors in the Esophagogastric Junction, Duodenum and Pancreas: Case Report and Review of the Literature. Front Oncol. 2022 May 30;12:890587. doi: 10.3389/fonc.2022.890587. PMID: 35707359; PMCID: PMC9190262.
10. Shin SJ, Park H, Sung YN, et al. Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only. Cancer Res Treat. 2018 Oct;50(4):1175-1185. doi: 10.4143/crt.2017.494. Epub 2017 Dec 20. PMID: 29268568; PMCID: PMC6192923.
11. Lee YP, Lee JS, Kim HS, et al. Synchronous pancreatic adenocarcinoma and duodenal mucosa‑associated lymphoid tissue lymphoma: A case report. Medicine (Baltimore). 2024 Dec 27;103(52):e41173. doi: 10.1097/MD.0000000000041173. PMID: 39969306; PMCID: PMC11688084.
12. Hirai R, Omae K-ichi, Yodoya M, et al. A case report of a collision tumor composed of pancreatic ductal adenocarcinoma and peri-pancreatic mucosa-associated lymphoid tissue lymphoma. World J Surg Onc. 2023 Mar 28;21(1):110. doi:10.1186/s12957-023-02981-3
13. Izumi H, Furukawa D, Yazawa N, et al. A case study of a collision tumor composed of cancers of the bile duct and pancreas. Surg Case Rep. 2015 Dec;1(1):40. doi: 10.1186/s40792-015-0041-5. Epub 2015 May 9. PMID: 26943405; PMCID: PMC4747933.
14. Sastry A, Wayne M, Steele J, et al. Three synchronous, sporadic and separate periampullary and pancreatic tumors: more than a coincidence? World J Surg Oncol. 2014 Dec 13;12:382. doi: 10.1186/1477-7819-12-382. PMID: 25494951; PMCID: PMC4301858.
15. Ohtsubo K, Sato S, Sakaguchi H, et al. Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor. Front Oncol. 2025 Mar 27;15:1551038. doi: 10.3389/fonc.2025.1551038. PMID: 40236650; PMCID: PMC11997870.
16. Ahadova A, Gallon R, Gebert J, et al. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome. Int J Cancer. 2018 Jul 1;143(1):139-150. doi: 10.1002/ijc.31300. Epub 2018 Feb 23. PMID: 29424427.
17. Ye JX, Liu Y, Qin Y, et al. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients. World J Gastroenterol. 2015 Feb 7;21(5):1595-605. doi: 10.3748/wjg.v21.i5.1595. PMID: 25663779; PMCID: PMC4316102.
How to Cite
D'Avila, L., Tee, J. Y., Sharma, A., Alabraba, E., & ZaItoun, A. (2026). Synchronous medullary carcinoma of the pancreas and non-ampullary duodenal adenocarcinoma. Archive of Clinical Cases, 13(2), 56-66. https://doi.org/10.22551/2026.51.1302.10342
Section
Case Reports

How to Cite

D'Avila, L., Tee, J. Y., Sharma, A., Alabraba, E., & ZaItoun, A. (2026). Synchronous medullary carcinoma of the pancreas and non-ampullary duodenal adenocarcinoma. Archive of Clinical Cases, 13(2), 56-66. https://doi.org/10.22551/2026.51.1302.10342